Retatrutide, from Soma, represents a significant advance in metabolic regulation. This unique compound combines GLP-1 receptor agonist activity with another receptor engagement, showing impressive results in patient findings for weight improvement. Scientists believe this treatment is expected to represent a new option for people facing excess weig